Down Syndrome
5 competing products in clinical development for Down Syndrome.
Pipeline by Phase
Phase 23
Phase 32
All Products (5)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| E2020-Donepezil hydrochloride + E2020-Donepezil hydrochloride + Placebo | Eisai | Phase 2 | Completed | 35 |
| Donepezil HCl + Placebo | Eisai | Phase 2 | Completed | 35 |
| Aricept (donepezil hydrochloride) + Aricept (donepezil hydrochloride) + Placebo | Eisai | Phase 3 | Terminated | 32 |
| Aricept (Donepezil hydrochloride) + Placebo | Eisai | Phase 3 | Terminated | 32 |
| Donepezil hydrochloride (Aricept) | Eisai | Phase 2 | Terminated | 27 |